Literature DB >> 13397432

Clinical experience with carbutamide (BZ-55); a progress report.

R CAMERINI-DAVALOS, A MARBLE, H F ROOT.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/therapy; SULFANILAMIDE/related compounds; UREA/related compounds

Mesh:

Substances:

Year:  1957        PMID: 13397432     DOI: 10.2337/diab.6.1.74

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  4 in total

1.  [THE HEMATOLOGICAL RISK IN TREATMENT WITH HYPOCLYCEMIC SULFONAMIDES].

Authors:  F J TRAISSAC; C BERAUD; J DANGOUMAU
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

2.  Experience with glipasol (R. P. 2259)-an antidiabetic sulfonamide drug.

Authors:  T W DAVIS; R B KERR; A BOGOCH
Journal:  Can Med Assoc J       Date:  1959-07-15       Impact factor: 8.262

3.  Hepatitis caused by glipasol (R.P. 2259)--an antidiabetic sulphonamide drug.

Authors:  T W DAVIS; R B KERR; A BOGOCH
Journal:  Can Med Assoc J       Date:  1960-07-16       Impact factor: 8.262

4.  Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test.

Authors:  E F Pfeiffer; S Raptis
Journal:  Diabetologia       Date:  1972-02       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.